Buy me a coffee
Home › FDA recalls › Heparin Sodium Injection
CLASS II · ModerateFDA

Shenzhen Techdow Pharmaceutical Co., Ltd. recalls Heparin Sodium Injection

📅 Oct 1, 2026 · 📍 Nationwide
Recalling company
Shenzhen Techdow Pharmaceutical Co., Ltd.
Product
Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01
Reason
Lack of Assurance of Sterility
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
Oct 1, 2026
Reported
Oct 28, 2026
Distribution
Nationwide in the USA.
Status
Ongoing
Quantity
251,000 1 mL multidose vials
Lot / codes
Lot# CU03232A, Exp 1/31/2028
Company location
Shenzhen
Recall type
Voluntary: Firm initiated
Recall number
D-0050-2027
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0050-2027 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.